*** Disclaimer: This Database is still undergoing update on daily basis to prevent errors, discrepancies, and missing records. Please Contact FDIC@nafdac.gov.ng for enquires ***

Product Details

Apretude 30 mg film coated tablets

Cabotegravir
30 mg
Film coated tablet

ROA

Oral

Applicant Name

GlaxoSmithKline Pharmaceutical Nig. PLC (GSK)

NRN

A4-100536

Status

Active


ATC Code

J05AJ04  

Product Category

Drugs

Marketing Category

Prescription-only Medicine (POM)  

Packsize

30  

Product Description

30 NF-PP-335435 Apretude 30 mg film coated tablets Cabotegravir cabotegravir 30 mg, Lactose Monohydrate Microcystalline Cellulose Hypromellose (E464) Sodium Starch Glycolate (Type A) Magnesium Stearate, Hypromellose (E464) Titanium Dioxide (E171), Macrogol 400 (E1521) Drugs Imported Products 30 Prescription Only Medicine (POM) 6/22/2023 GLAXOSMITHKLINE PHARMACEUTICAL NIGERIA LTD., INDUSTRIAL AVENUE ILUPEJU LAGOS 12711000 regulatorypharma-ng@gsk.com Glaxo Operations UK Ltd (trading as Glaxo Wellcome Operations), Priory Street Ware Hertfordshire SG12 0DJ UK, United Kingdom

Manufacturer Name

Glaxo Operations UK Limited

Manufacturer Country

UNITED KINGDOM  

Approval Date

2023-09-28  

Expiry Date

2028-09-27